CT结肠成像在65岁及以上成人中检测息肉和癌的性能:系统综述与Meta分析
该系统综述与Meta分析纳入34项研究、41680例受试者(其中18798例为高龄者),评估CT结肠成像在高龄(≥65岁)人群中检测病变的表现。高龄无症状筛查者以10 mm阈值计算的CTC阳性率为8.2%,该人群进展期肿瘤阳性预测值高(84.3%),CRC敏感度为93.0%。
要点
- 高龄无症状筛查人群10 mm阈值CTC阳性率8.2%,约每12例有1例转诊结肠镜。
- 高龄人群10 mm阈值进展期肿瘤阳性预测值84.3%(95%CI 79.3-88.3%,I²=0.0)。
- 高龄人群CTC对CRC敏感度93.0%,低于此前的年轻人群为92.0%。
核心结论
- 高龄无症状筛查者以10 mm阈值平均约每12例中有1例转诊结肠镜,进展期肿瘤检出率高且癌检测敏感度高。
- 有CRC症状的65岁及以上人群CTC阳性率高于无症状人群。
- 结果可帮助美国医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)确定Medicare受益人的CTC筛查覆盖。
研究设计与样本
- 系统综述与Meta分析,检索1994年1月至2017年8月发表的CTC研究。
- 共纳入34项研究、41680例受试者,其中高龄(≥65岁)受试者18798例。
- 主要终点为10 mm及以上大肠息肉和肿块的CTC阳性率,次要终点包括≥6 mm病变、证实的进展期肿瘤和结直肠癌(CRC)。
- 采用随机效应模型和Meta回归分析生成合并估计并探索影响因素。
诊断标准与关键数值
- 高龄人群10 mm阈值CTC阳性率:无症状人群8.2%(95%CI 6.0-11.1%),粪便隐血阳性人群32.8%(95%CI 15.4-56.7%),有其他CRC症状人群14.0%(95%CI 12.0-16.1%)。
- 高龄人群10 mm阈值结肠镜进展期肿瘤阳性预测值84.3%(95%CI 79.3-88.3%,I²=0.0)。
- 高龄人群CTC对CRC敏感度93.0%(95%CI 89.0-95.0%),年轻人群为92.0%(95%CI 84.0-93.0%)。
- 高龄成人CTC检出率总体高于年轻成人。
临床应用与阅片要点
- 高龄无症状筛查者以10 mm为阈值时,约每12例中有1例转诊结肠镜。
- 高龄有CRC症状人群CTC阳性率高于无症状人群,解读时应结合临床背景。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: We sought to perform a systematic review and meta-analysis of published CT colonography (CTC) studies assessing lesion detection in senior-age (≥ 65 years old) cohorts.
MATERIALS AND METHODS: We conducted a systematic review of CTC studies published between January 1994 and August 2017 containing data on senior-age adults. The primary endpoint was the CTC-positive rate for large colorectal polyps (≥ 10 mm) and masses. Secondary endpoints included lesions ≥ 6 mm, proven advanced neoplasia, and colorectal cancer (CRC). Study authors were contacted for additional missing data. Random-effects and meta-regression analyses were used to generate pooled estimates and explore contributing factors.
RESULTS: A total of 34 studies with 41,680 (18,798 senior-age) subjects were included. Pooled CTC-positive rates among senior-age patients using the 10-mm size threshold were significantly lower in cohorts of patients with no symptoms (8.2%; 95% CI, 6.0-11.1%) compared with cohorts of patients with positive fecal occult blood tests (32.8%; 95% CI, 15.4-56.7%) and other symptoms of CRC (14.0%; 95% CI, 12.0-16.1%). However, a uniformly high positive predictive value for advanced neoplasia at colonoscopy was seen for all senior-age cohorts using a 10-mm threshold (84.3%; 95% CI, 79.3-88.3%; I2 = 0.0) where such data were available. CTC sensitivity for CRC was 93.0% (95% CI, 89.0-95.0%) in senior-age patients compared with 92.0% (95% CI, 84.0-93.0%) in younger patients. Overall, CTC detection rates were higher in senior-age adults compared with younger adults.
CONCLUSION: On average, one in every 12 senior-age adults without symptoms of CRC who underwent screening would be referred to colonoscopy using the 10-mm threshold, with a high yield for advanced neoplasia and high sensitivity for cancer detection. As expected, CTC-positive rates were higher in cohorts of patients 65 years old or older with symptoms of CRC. These results should help inform the Centers for Medicare & Medicaid Services regarding coverage determination of CTC screening for Medicare beneficiaries.
引用
- Pickhardt PJ, Correale L, Delsanto S, et al. CT Colonography Performance for the Detection of Polyps and Cancer in Adults ≥ 65 Years Old: Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 29667892. doi:10.2214/AJR.18.19515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。